Hostname: page-component-74656f9884-c52kr Total loading time: 0 Render date: 2026-11-07T06:05:49.576Z Has data issue: false hasContentIssue false

Stimuli responsive polymer-based strategies for polynucleotide delivery

Published online by Cambridge University Press:  24 April 2017

Metin Uz
Affiliation:
Department of Chemical and Biological Engineering, Iowa State University, Ames, Iowa 50011, USA
Sacide Alsoy Altinkaya
Affiliation:
Department of Chemical Engineering, Izmir Institute of Technology, Izmir 35430, Turkey
Surya K. Mallapragada*
Affiliation:
Department of Chemical and Biological Engineering, Iowa State University, Ames, Iowa 50011, USA
*
a) Address all correspondence to this author. e-mail: suryakm@iastate.edu

Abstract

In recent years, stimuli responsive polymer based gene delivery vehicle design for cancer treatment and treatment of other genetic disorders has received extensive attention. Early studies focusing on DNA delivery have been facilitated by functional polymers and this area has seen further growth spurred by recent gene silencing strategies developed for small RNA [i.e., small interfering RNA (siRNA) or micro RNA (miRNA)] delivery. DNA and small RNAs possess analogous properties; however, their explicit differences define the specific challenges associated with the delivery route and the design of functional materials to overcome distinct challenges. Apart from classical gene delivery, the recent advances in genome editing have revealed the necessity of new delivery devices for genome editing tools. A system involving CRISPR (clustered, regularly interspaced, short palindromic repeats) and an endonuclease CRISPR-associated protein 9 (Cas9) coupled with a short, single-guide RNA (sgRNA) has emerged as a promising tool for genome editing along with functional delivery systems. For all these nucleic acid based treatments, the internal or external physiochemical changes in the biological tissue/cells play a major role in the design of stimuli responsive delivery materials for both in vitro and in vivo applications. This review emphasizes the recent advances in the use of pH, temperature, and redox potential-responsive polymers overcoming hurdles for delivery of gene and gene editing tools for both in vitro and in vivo applications. Specifically the chapter focuses on recently proposed delivery strategies, types of delivery systems, and polymer synthesis/modification methods. The recent advances in CRISPR/Cas9-sgRNA technology and delivery are also described in a separate section. The review ends with current clinical trials, concluding remarks, and future perspectives.

Information

Type
Invited Reviews
Copyright
Copyright © Materials Research Society 2017 
Figure 0

FIG. 1. Barriers for gene (DNA or small RNAs) delivery.

Figure 1

FIG. 2. Synthesis of star-branched PLA-PDMAEMA block copolymers. Reproduced with permission from Elsevier.74

Figure 2

FIG. 3. pH-responsive photopolymerized diacetylenic amphiphile (PDA) micelles for the intracellular siRNA delivery. Reproduced with permission from American Chemical Society.76

Figure 3

FIG. 4. Illustration of POEAAs mediated controlled DNA release and serum tolerance. Reproduced with permission from Elsevier.91

Figure 4

FIG. 5. Thermoresponsive block copolymers comprised of poly(N-isopropylacrylamide) and of poly[(3-acrylamidopropyl)trimethylammonium chloride] blocks for enhanced in vitro siRNA delivery. Reproduced with permission from American Chemical Society.116

Figure 5

FIG. 6. Schematic illustration of R11-SSPEI/miR-145 polyplex synthesis. Reproduced with permission from Elsevier.130

Figure 6

TABLE I. Polymer based stimuli responsive gene (DNA and small RNAs) delivery vectors.

Figure 7

FIG. 7. Structure of pentablock copolymers. The number of repeating units of the PDEAEM blocks, n, was varied to control the properties of the copolymer. Reproduced with permission from Elsevier.68

Figure 8

FIG. 8. Multi-stimuli sensitive amphiphilic block copolymer assemblies. Reproduced with permission from American Chemical Society.148

Figure 9

FIG. 9. Schematic representation of the CRISPR/Cas9 complex. (a) The CRISPR/Cas9 system with a single guide RNA (sgRNA) and CRISPR-associated protein 9 (Cas9). (b) The target DNA sequence. (c) sgRNA targets the complementary target DNA sequence, and Cas9 nuclease follows to generate a double stranded break at the target site. Reproduced with permission from Elsevier.158